Director Brent L Saunders bought 40,450 SKIN shares at $1.08 on 2024-08-12; stock now -82.3% from 52-week high.
Director Brent L Saunders purchased 40,450 shares at $1.08, a modest increment to his 5.88M share position (0.7% increase), as Beauty Health traded near its 52-week low of $1.12. The company reported $90.6M in latest quarterly revenue with only $202.0K net income and was unprofitable over its most recent full fiscal year, indicating fundamental operational challenges. Saunders' prior buy at this same ticker on 2023-08-16 returned +10.3% in 30 days but -77.2% in 90 days, establishing a pattern of deteriorating performance post-purchase at SKIN. The current stock price of $1.26 is -37.3% below where it traded 30 days ago and -54.5% below where it traded 90 days ago, consistent with the downward momentum observed following his previous SKIN acquisition.